Skip to main content
OpenTrials

Clinical trial condition

Hypergammaglobulinemia

Explore clinical trials studying Hypergammaglobulinemia. Study availability and eligibility vary by location and protocol.

136 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Hypergammaglobulinemia trial results

Completed

A Real-world Study in Participants With Smoldering Multiple Myeloma

NCT06472778

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • CHRU de Tours - Hopital Trousseau Chambray-lès-Tours, France
  • CHU Montpellier Montpellier, France
  • Centre Hospitalier Regional d'Orleans (CHRO) - Hopital La Source Orléans, France
  • Hopital Pitie Salpetriere Paris, France
View all 29 locations
View Trial Details
Completed

A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma

NCT03301220

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Arizona Oncology Associates, PC - HAL Phoenix, Arizona, United States
  • Innovative Clinical Research Inc Whittier, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 163 locations
View Trial Details
Completed

Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma

NCT01222286

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Mount Sinai School of Medicine New York, United States
  • Ohio State University Columbus, Ohio, United States
  • Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions